|Publication number||US2434688 A|
|Publication date||Jan 20, 1948|
|Filing date||Nov 3, 1942|
|Priority date||Nov 3, 1942|
|Publication number||US 2434688 A, US 2434688A, US-A-2434688, US2434688 A, US2434688A|
|Inventors||Ralph L Evans|
|Original Assignee||Ralph L Evans|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (3), Referenced by (48), Classifications (12)|
|External Links: USPTO, USPTO Assignment, Espacenet|
Patented Jan. 1948 UNITED snares PATENT}: orn cg No Drawing. Application November 3, 1942,
Serial No. 464,428 I 14 Claims. 1
This invention relates to processes for preparing regenerated keratin and the products thereof. It relates particularly to improved methods for dissolving keratin without substantially changing the polypeptide linkages thereof. Certain embodiments relate to chemical derivatives of regenerated keratin.
Keratin is found in certain varieties of horn. Of greater importance is the fact that keratin is found in fibrous form in wool, fur, mohair and the like. The physics and chemistry of keratin is of particular interest in connection with the art of reshaping wool for making artificial Persian lamb fur coats and the like. j
For many years the prior art has known: That proteins are made .up of amino acids; that the carboxyl (-COzH) group of one amine acid 18 chemically bound to the amino (-NHz) group of another amino acid molecule in the protein; that said carboxyl-amino r peptide (CONH--) linkages are easily hydrolyzed or split by water under suitable reaction conditions such as high temperature, pH, etc.; that a great number of amino acid molecules are united to form a polypeptide chain; that the polypeptide chains of keratin are normally folded in a generally random manner; that the polypeptide chains of keratin, although not as orderly arranged as ions in an inorganic crystal, are generally axially oriented in the fiber; and that keratin fibers are characterized by cross linkages of cystine. For many decades it has been known that keratin contains cystine HO2CCHNH2CH2SSCH2CHNH2CO2H which is rather easily reduced to two molecules of cysteine HOzCCHNHzCHzSH. Cysteine is in turn rather easily oxidized to cystine; however, unless the reaction conditions are properly controlled, the oxidation ma proceed to the formation of Z-amino, 2-carboxylic ethanesulfonic acid,
HOzCCHNHzCHaSOaH which can be reduced only with such extreme diificulty as to be economically infeasible. 1 v
A cysteine unit is furnished by each of the two long polyp ptide chains which are united by a cystine linkage. Thus, the SS- portion of a cystine cross link is at the middle thereof. It is sometimes helpful to think of a molecule in a keratin fiber as analogous to a ladder having rope rungs characterized by centrally disposed snap connectors easily engaged or disengaged. Reshaping of animal textile fibers is believed to involve a disconnection of the cross rungs, a, stretching and reshaping of the fiber to relatively and axially shift the long polypeptide units, and a reconnection of the cross rungs to stabilize the long 2 polypeptide units in their new relationship and shape. Chemically, such fiber reshaping is believed to involve: a reduction of some of the cystine to cysteine; pressure phenomena; and an oxidation of some of the-cysteine to cystine to restore the original chemical and essential structure of the keratin fiber. For convenience, a single cross linkage between two chains has been explained. However, it should be understood that a keratin fiber contains thousands of long polypeptide chains, and that a cross-section of such a fiber might cut through hundreds of chains. Moreover, a chain may be connected to each of a dozen or so adjacent parallel chains by means of cystine cross-linkages.
A pound of wool has about 1.42 times 10 cross-, Although, substantially all of the cyslinkages. tine of keratin probably provides cross linkages between parallel polypeptide chains, it is possible: that some of the cysteine units are chemically united with cysteine units in the same polypeptide chain to form heterocyclic units characterized by the disulfide SS- linkage; that some of the cysteine units are chemically united to other cys- 25,teine units of a. relatively independent branch of a long chain; and/or that some of the cysteine units are in some other relationship distinguishable vfrom the cross linkages.
Wool contains approximately 12.4% cystine. Cystine contains approximately 25% sulfur.
Thus, it has been calculated that wool containsapproximately 3.34% of cystine sulfur and that 959 grams of wool contain about 1 mole of cysteine sulfur.
It is an important object of the present invention to prepare regenerated keratin without injuriously afiecting the chemical or physical characteristics of the ,keratin material. It is an object of the present invention to dissolve keratin without breaking any of the polypeptide linkages. Further objects of certain-embodiments are to prepare keratin like material having improved characteristics, to prepare synthetic keratin fibers at a minimized cost, and to provide protein containing plastics of unusual strength and-water resistance.
A feature of the presentinvention is the utilization of a process of dissolving keratin at a lower pH than has heretofore been used. Features of certain embodiments include: the provision of chemical derivatives of keratin; the provision of synthetic fibers having unique physical characteristics; and the utilization of effective reducing agents prior to and/or simultaneously. with the dissolving of the keratin.
In describing the present invention in detail, reference may be made to examples. The terminology of these examples are for a purpose of illustration and not' for limitation. Although certain of the steps of the present invention can be conveniently described in terms of liquid treatment, it should be understood that gaseous reagents, paste reagents, and/or powdered reagents may be used satisfactorily.
In the preparation of regenerated keratin, two importantsteps are involved. The keratin must be dissolved and subsequently precipitated. In certain embodiments of the present invention, additional steps are provided.
Particular importance is placed upon the step of dissolving keratin in accordance with the present invention. Heretofore, keratin has been dissolved by means of strong alkaline solutions of a sulfide salt. However. damage is done to the keratin material by the high alkalinity of such a solution. Moreover, the odor of the alkaline sulfide is very objectionable because of its resemblance to the odor of rotten eggs. Because the damage to keratin by such methods is so extensive, and because the odor is so objectionable, there have been substantially no efforts to commercialize regenerated keratin processes.
It should be especially noted that, according to the present invention, keratin is dissolved at a relatively low pH. The keratin is first reduced by means of a non-sulfide reducing agent capable of effecting such reduction at a pH lower than 13.5. Particularly satisfactory results are obtained by the use of an alkanthiol as a reducing agent. Benzylthiol, furfurylthiol, hydroxyalkanthiols, thioglycollic acid, other methanthiol derivatives, and numerous other related materials, whether in acid, basic or neutral media, are included within the term alkanthiol. Alkanthiols having no additional functional groups can be effectively used as reducing agents for this step if suitable ventilating means are used to remove the offensive odor incident thereto. The use of alkanthiols having additional functional groups ordinarily avoids the objectionable odor. Derivatives having strong polar groups, such as thioglycollic acid, are quite effective. However, by reason of the fact that polar groups ionize when dissolved, whereas non-polar groups do not, even more satisfactory results can be obtained by the functional groups of a relatively non-polar nature. For example, thioglycerol is a very effective reducing agent for the preparation of regenerated keratin. Thiosorbitol, thiomannitol and other polyhydroxyalkanthiols are very satisfactory.
The molal concentration of the alkanthiol and/or alkanthiol derivative should be at least .2 and should desirably be about .5. It is ordinarily not necessary to increase the molal concentration of alkanthiol above 1.5. However, it should be understood that an effective reduction of keratin can be achieved at molal concentrations of alkanthiol as low as .1 and substantially higher than 1.5.
The temperature of the reduction influences the' speed of the reaction. However, the speed of the hydrolysis of the polypeptide linkages is also increased at high temperatures. In order to avoid undue hydrolysis and in order to avoid the expense of maintaining high temperatures, it is ordinarily desirable to reduce keratin at a temperature below 55 C. to 60 C. The pH of the reducing solution should be above 3 and below 4 13.5. In order to dissolve the reduced keratin. a solution having a pH between 9 and 13.5 should be used. Although the reducing and dissolving can be conveniently described separately, it
ls/should be understood that such terminology is intended to generically define not only the two step but also the one step reducing and dissolving operations.
Examples of the step of reducing and dissolving 10 keratin in accordance with the present invention follow:
Example 1.-50 grams of horn, human hair waste, wool waste, and/or cowhair clippings are dissolved in 1 liter of .5 molal thioglycollic acid containing Ca(OH)2 to bring the solution to a pH of 12.5. The reaction is carried on at 50 C. for 20 minutes, by which time the keratin is substantially dissolved.
Example 2.1,000 grams of human hair waste are dissolved in 50 liters of .2 molal ethylmercaptan containing NaOH to bring the pH to 13.4. The reaction is carried on at 45 C. for 25 minutes, by which time the keratin is substantially dissolved.
Example 3.150 grams of wool waste are dissolved in 1 liter of 1.5'molal thioglycerol containing NaOH to produce a pH of 13.3. The reaction mixture will dissolve the keratin after 3 hours at room temperature.
While the keratin is in its reduced state, it may be subjected to any of several treatments.
Example 4.--Methylchloride is reacted with a solution of dissolved keratin to produce a methyl derivative of keratein. Instead of methyl- 5 chloride, aliphatic homologues or any aryl compounds, such as benzylchloride, CBHSCHZCI, may be used. Instead of any alkylchloride, there may be used an alkylbromide, an alkyliodide, or other compound having a functional group capable of 40 reacting with cysteine sulfur to attach an organic group to the cysteine sulfur.
Ewample 5.-Ethylene chloride is reacted with a solution of reduced keratin to form bisthioether cross linkages in the keratin. Other dichloro compounds, or other reagents (e. g. ketene,
acetaldehyde and the like) capable of reacting to attach an organic group to two cysteine sulfur units may be used instead of ethylene-chloride.
Example 6.-Ketene. formaldehyde, benzaldehyde, or the like can be reacted with a solution use of alkanthiol derivatives having additional of reduced keratin to produce material having organic groups attached not only to the cysteine sulfur but also to NH: and other reactive groups of the keratin.
Although it is ordinarily not desirable, the keratin can be precipitated by controlling the reaction conditions in the above Examples 4, 5 and 6.
It is ordinarily desirable to precipitate the keratin as a separate step. The precipitation of the keratin maybe conveniently achieved by the addition of suflicient acid to decrease the pH of the solution to about 4.5. The keratin can be prepared by centrifuging, drying, or other suitable 5 methods.
Example 7.The solution prepared according to Example 3 is treated with 21 ml. of 10 normal H2804 to precipitate the keratin material.
Example 8.-A solution of reduced keratin is 0 spun into an acid (pH5) precipitating solution containing an oxidizing agent such as H202 adapted to reform cystine cross linkages.
Important advantages of the regenerated fibers of the present invention are that they are very 7 strong and may have a tensile strength greater than 85% of the average tensile strength of wool. Moreover, they have polypeptide chains substantially as long as those in wool.
As previously explained, the solution of reduced keratin is not necessarily treated according to Examples 4, 5 or 6. After the keratin has been precipitated, the non-fibrous mass may, if desired, be treated with any of the reagents mentioned in Examples 4, 5, and 6. The precipitated keratin can be utilized in any one of several ways.
If it is desired to make a thermo-setting'material therefrom, condensing reagents such as formaldehyde, crotonaldehyde, or the like, can be mixed with the precipitated mass, which can then be molded in conventional molding machines. The heat of the mold will accelerate the reaction between the reduced keratin and condensing reagent. and convert the material to a thermosetting plastic. The material thus formed possesses less hygroscopicity than other plastics derived from proteins. The hygroscopicity and tendency to swell in water can be minimized by reacting the reduced keratin with a long chain reagent capable of attaching to the cysteine sulfur and utilizing a condensing reagent of high molecular weight, such as benzaldehyde.
Synthetic fibers may be formed from the dough-like plastic mass prepared as above, by extruding it in fibrous form. The initially prepared solution of reduced keratin may be extruded through spinnerettes into an acid precipitating bath. Particularly satisfactory results are obtained by: dissolving the keratin with an alkanthiol derivative reducing agent of pH 9-125; precipitating the keratin by decreasing the pH to about 4.5; treating the precipitated mass with just enough alkaline solution (pH about 12.5) to form a gel; working and aging the gel to improve its physical characteristics; and extruding the gel through fine spinnerettes into a precipitating medium.
After the initial formation of the fiber, it is desirably stretched, relaxed, and restretched in order to axially orient the polypeptide chains. The fiber is desirably prepared as a reduced keratin fiber. After stretching and other physical treatment, the reduced keratin is chemically modified in order to permanently retain the physical characteristics thus achieved. H2O: or other suitable oxidizing agent may be used to oxidize the cysteine and to form new cystine cross linkages. However, particularly satisfactory results are obtained by reacting the reduced keratin with ethylene-chloride or other reagents capable of forming bisthioether cross linkages. After suitable thiol cross linkages have been formed, the fiber may be reacted with a suitable condensation reagent such as ketene or formaldehyde to harden the fiber.
1. The method of preparing a modified keratin comprising reducing the keratin with a non-polar mercaptan in an aqueous solution having a pH above 3 and below 13.5, dissolving the reduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin in an acid precipitating bath.
2. The method of preparing a modified keratin comprising reducing the keratin with a non-polar hydroxyalkanthiol in an aqueous solution having a pH above 3 and below 13.5, dissolving the reduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin in an acid precipitating bath.
3. The method of preparing a modified keratin comprisingreduciug the keratin with a non-polar.
above 3 and below 13.5, dissolving thereduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin with an acid bath containing an oxidizing agent. v v
4. A new composition of matter comprising a modified keratin prepared by reducing keratin with a non-polar mercaptan in an aqueous solution having a pH above 3 and below 13.5, dissolving the reduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin in an acid precipitating bath.
5. A new composition of matter comprising a modified keratin prepared by reducingkeratin with a non-polar hydroxyalkanthiol in an aqueous solution having a pH above 3 and below 13.5, dissolving the reduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin in an acid precipitating bath.
6. A new composition of matter comprising a modified keratin prepared by reducing keratin with a non-polar mercaptan in an aqueous solution having a pH above 3 and below 13.5, dissolving the reduced keratin in an aqueous alkaline solution having a pH between 9 and 13.5 and precipitating the modified keratin with an acid bath containing an oxidizing agent.
7. The method which includes: treating and dissolving keratin with an aqueous alkaline solution having a pH between 9 and 13.5 and containing a non-polar hydroxyalkanthiol reducing agent between 0.1 and 1.5 molarity to reduce the keratin without materially hydrolyzing its amide linkages; and subsequently precipitating the modified reduced keratin with an acid.
8. The method which includes: treating keratin with an aqueous alkaline solution having a pH between 9 and 13.5 and containing a non-polar mercaptan reducing agent of about 0.5 molarity to dissolve the keratin without materially hydrolyzing its amide linkages; and subsequently precipitating the modified keratin with an acid.
9. The method which includes: treatment of keratin with an aqueous alkaline solution having a pH between 9 and 13.5 and containing at least 0.1 M non-polar hydroxyalkanthiol reducing agent to dissolve the keratin without materially hydrolyzing its amide linkages; forming a fiber by spinning the solution into an acid precipitating bath and stretching the so-formed fiber.
10. In the treatment of keratin the method which comprises; reducing at least some of the cross linkages or SS bonds by treatment with an aqueous alkaline solution having a pH between 9 and 13.5 and containing a non-polar mercaptan; precipitating with acid to produce a modified keratin mass; and treating the mass with an aldehyde.
11. The process comprising the steps of: treating keratin with an aqueous alkaline solution having a pH between 9 and 13.5 and containing a non-polar mercaptan to reduce at least some of the cystine SS linkages and to form a solution Of reduced keratin; extruding the reduced keratin material into an acid bath to form fibers from the reduced keratin; stretching said fibers to orient keratin chains parallel to the fiber axes; and treating the reshaped modified keratin with an aldehyde.
12. The process comprising treating keratin with an aqueous alkaline solution having a pH ensues between 9 and 13.5 and containing a non-polar mercaptan to reduce at least some of the cystine --SS linkages to form a solution of reduced keratin, extruding the solution into an acid precipitating bath to form fibers from the reduced keratin; stretching; relaxing; and restretching said fibers to orient keratin chains parallel to the fiber axes, and treatingthe reshaped keratin with an aldehyde.
13. A new composition of matter comprising a modified keratin prepared by treating keratin with an aqueous alkaline solution having a pH between 9 and 13.5 and containing a non-polar mercaptan to reduce at least some of the SS-- linkages to form a solution of the reduced keratin; subjecting the reduced keratin to an acid bath and treating this modified keratin with an aldehyde.
14. The process which includes the step of dissolving keratin in an aqueous alkaline solution containing a non-polar hydroxyalkanthiol and having a pH between 9 and 13.5; precipitating the keratin by decreasing the pH to its acid range and dissolving the precipitated mass with just sufficient alkaline solution to form a gel; working and aging the gel; extruding the gel through fine spinnerettes into an acid precipitating bath to term fibers; and treating the fibers with an aldehyde.
RALPH L. EVANS.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 2,201,929 Speakman May 21, 1940 FOREIGN PATENTS Number Country Date 830,101 France May 9, 1938 538,338 Great Britain July 30, 1941 OTHER REFERENCES J. Am. Leather Chemists Assn, vol. am, No. 11, Nov. 1935, A Study of Keratin, Leonor Michaelis, pp. 557 to 568.
Goddard and Michaelis, J. Biol. Chem., Studies on Keratin, vol. 106 (1934), pp. 605-614. Copy in Sci. Library.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2201929 *||Dec 9, 1935||May 21, 1940||Bamber Speakman John||Treatment of fibers or fibrous materials containing keratin|
|FR830101A *||Title not available|
|GB538338A *||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US2542984 *||Feb 25, 1949||Feb 27, 1951||Charles H Binkley||Method of solubilizing keratin|
|US2623039 *||May 2, 1949||Dec 23, 1952||Rochester Button Co||Thermosetting keratinoid compositions and method of making the same|
|US2739033 *||Mar 19, 1951||Mar 20, 1956||Du Pont||Treatment of reduced keratinous materials with alpha,alpha'-dihalodicarboxylic acid|
|US3957065 *||Sep 5, 1974||May 18, 1976||Henkel & Cie G.M.B.H.||Agents for permanent waving of human hair containing keratein and process for using the same|
|US3961634 *||Jul 23, 1974||Jun 8, 1976||Henkel & Cie G.M.B.H.||Hair bleaching preparations containing keratose and processes of using the same|
|US5047249 *||Mar 3, 1989||Sep 10, 1991||John Morris Co., Inc.||Compositions and methods for treating skin conditions and promoting wound healing|
|US6783546||Mar 22, 2001||Aug 31, 2004||Keraplast Technologies, Ltd.||Implantable prosthetic or tissue expanding device|
|US6849092||Mar 8, 2001||Feb 1, 2005||Keraplast Technologies, Ltd.||Implantable prosthetic or tissue expanding device|
|US6914126||Apr 10, 2002||Jul 5, 2005||Keraplast Technologies, Ltd.||Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks|
|US6989437||Apr 26, 2002||Jan 24, 2006||Keraplast Technologies, Ltd.||Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks|
|US7001987||Apr 22, 2002||Feb 21, 2006||Keraplast Technologies, Ltd.||Hydrogel with controllable mechanical, chemical, and biological properties and method for making same|
|US7001988||Sep 25, 2002||Feb 21, 2006||Keraplast Technologies, Ltd.||Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same|
|US7501485||Jan 28, 2003||Mar 10, 2009||Keraplast Technologies, Ltd.||Bioactive keratin peptides|
|US8258093||Sep 23, 2011||Sep 4, 2012||Wake Forest University Health Sciences||Wound healing compositions containing keratin biomaterials|
|US8273702||Apr 17, 2008||Sep 25, 2012||Wake Forest University Health Sciences||Wound healing compositions containing keratin biomaterials|
|US8299013||Feb 16, 2007||Oct 30, 2012||Wake Forest University Health Sciences||Clotting and healing compositions containing keratin biomaterials|
|US8324346||Feb 26, 2009||Dec 4, 2012||Keraplast Technologies, Ltd.||Bioactive keratin peptides|
|US8545893||Mar 8, 2011||Oct 1, 2013||Wake Forest University Health Sciences||Keratin biomaterials for treatment of ischemia|
|US8637231||Aug 11, 2011||Jan 28, 2014||Wake Forest University Health Sciences||Method for increasing the volume of a blood substitute with an expander comprising basic alpha keratose|
|US8920827||Oct 16, 2006||Dec 30, 2014||Wake Forest University Health Sciences||Keratin bioceramic compositions|
|US8968764||Jan 18, 2011||Mar 3, 2015||Wake Forest University Health Sciences||Nerve regeneration employing keratin biomaterials|
|US9068162||Feb 12, 2010||Jun 30, 2015||Wake Forest University Health Sciences||Keratin biomaterials for cell culture and methods of use|
|US9149566||Feb 15, 2007||Oct 6, 2015||Wake Forest University Health Sciences||Coatings and biomedical implants formed from keratin biomaterials|
|US9220754||May 16, 2013||Dec 29, 2015||Wake Forest University Health Sciences||Keratin compositions for treatment of bone deficiency or injury|
|US20010047082 *||Jul 2, 2001||Nov 29, 2001||Van Dyke Mark E.||Soluble keratin peptide|
|US20030119089 *||Sep 25, 2002||Jun 26, 2003||Dyke Mark Van||Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same|
|US20030204037 *||Apr 26, 2002||Oct 30, 2003||Van Dyke Mark E.||Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks|
|US20030219486 *||Apr 10, 2002||Nov 27, 2003||Van Dyke Mark E.||Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks|
|US20030224052 *||Apr 22, 2002||Dec 4, 2003||Van Dyke Mark E.||Hydrogel with controllable merchanical, chemical, and biological properties and method for making same|
|US20030228353 *||Jan 28, 2003||Dec 11, 2003||Keraplast Technologies, Ltd.||Bioactive keratin peptides|
|US20040062793 *||Apr 10, 2003||Apr 1, 2004||Dyke Mark Van||Tissue defect dressings comprising proteinaceous networks|
|US20040076599 *||Apr 8, 2003||Apr 22, 2004||Southwest Research Institute||Keratin-based powders and hydrogel for pharmaceutical applications|
|US20040082717 *||Jun 24, 2003||Apr 29, 2004||Southwest Research Institute||Keratin-silicone copolymers and interpenetrating networks (IPN's), methods of production and methods of use thereof|
|US20040120910 *||Sep 29, 2003||Jun 24, 2004||Dyke Mark Van||Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks|
|US20050058686 *||Jul 25, 2003||Mar 17, 2005||Mark Van Dyke||Bioactive coating for medical devices|
|US20050169963 *||Jan 31, 2005||Aug 4, 2005||Southwest Ressearch Institute||Implantable prosthetic or tissue expanding device|
|US20070166348 *||Oct 16, 2006||Jul 19, 2007||Van Dyke Mark E||Keratin bioceramic compositions|
|US20080089930 *||Nov 27, 2007||Apr 17, 2008||Keraplast Technologies, Ltd.||Keratin-Based Powders and Hydrogel for Pharmaceutical Applications|
|US20080274165 *||Apr 17, 2008||Nov 6, 2008||Wake Forest University Health Sciences||Wound healing compositions containing keratin biomaterials|
|US20090004242 *||Feb 15, 2007||Jan 1, 2009||Van Dyke Mark E||Coatings and Biomedical Implants Formed From Keratin Biomaterials|
|US20090047260 *||Aug 15, 2008||Feb 19, 2009||Wake Forest University Health Sciences||Keratin biomaterials for cell culture and methods of use|
|US20090148488 *||Feb 20, 2009||Jun 11, 2009||Keraplast Technologies, Ltd.||Bioactive coating for medical devices|
|US20110070276 *||Feb 26, 2009||Mar 24, 2011||Keraplast Technologies, Ltd.||Bioactive keratin peptides|
|US20110137329 *||Jan 18, 2011||Jun 9, 2011||Dyke Mark E Van||Nerve regeneration employing keratin biomaterials|
|US20110142910 *||Feb 16, 2007||Jun 16, 2011||Van Dyke Mark E||Clotting and Healing Compositions Containing Keratin Biomaterials|
|US20110217285 *||Mar 8, 2011||Sep 8, 2011||Van Dyke Mark E||Keratin biomaterials for treatment of ischemia|
|US20110217356 *||Mar 7, 2011||Sep 8, 2011||Van Dyke Mark E||Controlled delivery system|
|WO2003035722A1 *||Sep 25, 2002||May 1, 2003||Southwest Research Institute||Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same|
|U.S. Classification||264/202, 8/127.6, 530/357, 530/842, 106/154.11|
|International Classification||C08H1/06, D01F4/00|
|Cooperative Classification||C08H1/06, Y10S530/842, D01F4/00|
|European Classification||C08H1/06, D01F4/00|